MM
IRWD icon

MQS Management’s Ironwood Pharmaceuticals IRWD Stock Holding History

MQS Management’s Portfolio IRWD Stock Details IRWD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-11,451
Closed -$40.2K – 379
2026
Q1 		$40.2K Sell
11,451
-963
-8% -$3.95K 0.03% 366
2025
Q4 		$41.8K Buy
+12,414
New +$32.2K 0.02% 386
2024
Q1 		– Sell
-27,908
Closed -$319K – 571
2023
Q4 		$319K Sell
27,908
-1,158
-4% -$11.5K 0.18% 247
2023
Q3 		$280K Buy
+29,066
New +$285K 0.17% 265
2022
Q4 		– Sell
-20,729
Closed -$215K – 479
2022
Q3 		$215K Buy
20,729
+9,048
+77% +$103K 0.14% 329
2022
Q2 		$135K Buy
+11,681
New +$138K 0.09% 344

Other funds holding IRWD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
SCM
Sarissa Capital Management Greenwich, Connecticut $178M AUM 118.43% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

MQS Management's IRWD Position: Q2 2026 in Review

MQS Management sold out of Ironwood Pharmaceuticals (IRWD) in Q2 2026, closing a stake of 11,451 shares — an estimated $40.2K sold.

MQS Management first reported a position in IRWD in Q2 2022 and held it in 6 quarters. The position peaked at $319K in Q4 2023. 212 funds tracked by Wall St. Rank hold IRWD as of Q2 2026.

  • MQS Management reported no remaining Ironwood Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
  • MQS Management sold 11,451 Ironwood Pharmaceuticals shares in Q2 2026, an estimated $40.2K.
  • MQS Management first reported a position in Ironwood Pharmaceuticals in Q2 2022 and held it in 6 quarters.
  • MQS Management's Ironwood Pharmaceuticals position peaked at $319K in Q4 2023.
  • 212 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q2 2026.

Based on MQS Management's 13F filing for Q2 2026, filed 7 Aug 2026.